7-143478117-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_176883.2(TAS2R41):c.245G>A(p.Arg82Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,614,056 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_176883.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R41 | NM_176883.2 | c.245G>A | p.Arg82Gln | missense_variant | 1/1 | ENST00000408916.1 | NP_795364.2 | |
EPHA1-AS1 | NR_033897.1 | n.207-26657G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R41 | ENST00000408916.1 | c.245G>A | p.Arg82Gln | missense_variant | 1/1 | 6 | NM_176883.2 | ENSP00000386201.1 | ||
EPHA1-AS1 | ENST00000429289.5 | n.207-26657G>A | intron_variant | 1 | ||||||
EPHA1-AS1 | ENST00000690912.1 | n.228-17849G>A | intron_variant | |||||||
EPHA1-AS1 | ENST00000703017.1 | n.206-17849G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152064Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000161 AC: 40AN: 249108Hom.: 0 AF XY: 0.000178 AC XY: 24AN XY: 135152
GnomAD4 exome AF: 0.000108 AC: 158AN: 1461874Hom.: 1 Cov.: 43 AF XY: 0.000129 AC XY: 94AN XY: 727238
GnomAD4 genome AF: 0.000112 AC: 17AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74430
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at